{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:18:44Z","timestamp":1789906724712,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1124\/jpet.110.173955","type":"journal-article","created":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T03:41:51Z","timestamp":1301974911000},"page":"246-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Tamoxifen Regulation of Bone Growth and Endocrine Function in the Ovariectomized Rat: Discrimination of Responses Involving Estrogen Receptor \u03b1\/Estrogen Receptor \u03b2, G Protein-Coupled Estrogen Receptor, or Estrogen-Related Receptor \u03b3 Using Fulvestrant (ICI 182780)"],"prefix":"10.1016","volume":"338","author":[{"given":"James M.","family":"Fitts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Andrew","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.173955_bib1","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1210\/en.2008-0532","article-title":"ICI 182780 penetrates brain and hypothalamic tissue and has functional effects in the brain after systemic dosing","volume":"149","author":"Alfinito","year":"2008","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneuroim.2009.06.023","article-title":"Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis","volume":"214","author":"Blasko","year":"2009","journal-title":"J Neuroimmunol"},{"key":"10.1124\/jpet.110.173955_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nchembio775","article-title":"Virtual and biomolecular screening converge on a selective agonist for GPR30","volume":"2","author":"Bologa","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.110.173955_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.7-6-477","article-title":"FDA drug approval summaries: fulvestrant","volume":"7","author":"Bross","year":"2002","journal-title":"Oncologist"},{"key":"10.1124\/jpet.110.173955_bib5","doi-asserted-by":"crossref","first-page":"8880","DOI":"10.1073\/pnas.151244398","article-title":"4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor \u03b3","volume":"98","author":"Coward","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.110.173955_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1677\/joe.0.1340169","article-title":"Comparison of extraction methods for insulin-like growth factor-I in rat serum","volume":"134","author":"Crawford","year":"1992","journal-title":"J Endocrinol"},{"key":"10.1124\/jpet.110.173955_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/bcr79","article-title":"Estrogen receptor transcription and transactivation: Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action","volume":"2","author":"Curtis Hewitt","year":"2000","journal-title":"Breast Cancer Res"},{"key":"10.1124\/jpet.110.173955_bib8","first-page":"753","article-title":"Biochemical and ultrastructural studies on estrogen-induced pituitary tumors in F344 rats","volume":"61","author":"De Nicola","year":"1978","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.110.173955_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nchembio.168","article-title":"In vivo effects of a GPR30 antagonist","volume":"5","author":"Dennis","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1124\/jpet.110.173955_bib10","doi-asserted-by":"crossref","first-page":"H1806","DOI":"10.1152\/ajpheart.00283.2009","article-title":"Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats","volume":"297","author":"Deschamps","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.110.173955_bib11","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1210\/endo.136.3.7867556","article-title":"Estradiol and tamoxifen interactions with thyroid hormone in the ovariectomized-thyroidectomized rat","volume":"136","author":"DiPippo","year":"1995","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3565(24)36609-1","article-title":"Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat","volume":"281","author":"DiPippo","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.173955_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0960-0760(98)00033-8","article-title":"Effects of partial versus pure antiestrogens on ovulation and the pituitary-ovarian axis in the rat","volume":"66","author":"Donath","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/jpet.110.173955_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0022-3565(24)37599-8","article-title":"Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat","volume":"286","author":"Fitts","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.173955_bib15","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1210\/endo.142.10.8445","article-title":"Estrogen and tamoxifen interplay with T3 in male rats: pharmacologically distinct classes of estrogen responses affecting growth, bone, and lipid metabolism, and their relation to serum GH and IGF-I","volume":"142","author":"Fitts","year":"2001","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/j.1939-4640.2004.tb02823.x","article-title":"Comparison of tamoxifen and testosterone propionate in male rats: differential prevention of orchidectomy effects on sex organs, bone mass, growth, and the growth hormone-IGF-I axis","volume":"25","author":"Fitts","year":"2004","journal-title":"J Androl"},{"key":"10.1124\/jpet.110.173955_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jbmr.209","article-title":"GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice","volume":"26","author":"Ford","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1124\/jpet.110.173955_bib18","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/endo.133.6.8243306","article-title":"The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats","volume":"133","author":"Gallagher","year":"1993","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/hbeh.2000.1638","article-title":"Systemic ICI 182,780 alters the display of sexual behaviors in the female rat","volume":"39","author":"Gardener","year":"2001","journal-title":"Horm Behav"},{"key":"10.1124\/jpet.110.173955_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/er.2008-0017","article-title":"Transcriptional control of energy homeostasis by the estrogen-related receptors","volume":"29","author":"Gigu\u00e8re","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.110.173955_bib21","first-page":"717","article-title":"Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human","volume":"19","author":"Giustina","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.110.173955_bib22","doi-asserted-by":"crossref","first-page":"33639","DOI":"10.1074\/jbc.M402195200","article-title":"Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity","volume":"279","author":"Greschik","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.173955_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1097-2765(02)00444-6","article-title":"Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3","volume":"9","author":"Greschik","year":"2002","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.110.173955_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/CIRCRESAHA.108.190892","article-title":"Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity","volume":"104","author":"Haas","year":"2009","journal-title":"Circ Res"},{"key":"10.1124\/jpet.110.173955_bib25","first-page":"382","article-title":"Human ERR\u03b3, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult","volume":"14","author":"Heard","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.110.173955_bib26","first-page":"779","article-title":"Influence of diethylstilbestrol treatment on prolactin cells of female ACI and Sprague-Dawley rats","volume":"39","author":"Holtzman","year":"1979","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.110.173955_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2010.07.034","article-title":"Role of GPR30 in endometrial pathology after tamoxifen for breast cancer","volume":"203","author":"Ignatov","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1124\/jpet.110.173955_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007120","article-title":"Estrogen\/estrogen receptor \u03b1 signaling in mouse posterofrontal cranial suture fusion","volume":"4","author":"James","year":"2009","journal-title":"PLoS One"},{"key":"10.1124\/jpet.110.173955_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner"},{"key":"10.1124\/jpet.110.173955_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1210\/er.2003-0035","article-title":"Estrogen regulation of growth hormone action","volume":"25","author":"Leung","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.110.173955_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1210\/me.2009-0148","article-title":"Regulation of ERR\u03b1 gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by G-protein-coupled receptor GPR30\/GPER-1","volume":"24","author":"Li","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.110.173955_bib32","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1210\/en.2008-1664","article-title":"Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats","volume":"150","author":"Lindsey","year":"2009","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1095\/biolreprod.110.084160","article-title":"Expression and signaling of G protein-coupled estrogen receptor l (GPER) in rat sertoli cells","volume":"83","author":"Lucas","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1124\/jpet.110.173955_bib34","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/en.2008-0623","article-title":"Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice","volume":"150","author":"M\u00e5rtensson","year":"2009","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/rp.57.1.295","article-title":"Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist\/antagonist activities of selective estrogen receptor modulators","volume":"57","author":"McDonnell","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"10.1124\/jpet.110.173955_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1749-6632.1995.tb31376.x","article-title":"Responses to pure antiestrogens (ICI 164384, ICI 182780) in estrogen-sensitive and -resistant experimental and clinical breast cancer","volume":"761","author":"Nicholson","year":"1995","journal-title":"Ann NY Acad Sci"},{"key":"10.1124\/jpet.110.173955_bib37","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.bjc.6601629","article-title":"Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action","volume":"90","author":"Osborne","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1124\/jpet.110.173955_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1095\/biolreprod.108.071175","article-title":"GPR30 does not mediate estrogenic responses in reproductive organs in mice","volume":"80","author":"Otto","year":"2009","journal-title":"Biol Reprod"},{"key":"10.1124\/jpet.110.173955_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0303-7207(89)90052-X","article-title":"Differential responses of pituitary kallikrein and prolactin to tamoxifen and chlorotrianisene","volume":"66","author":"Powers","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.110.173955_bib40","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","article-title":"A transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"key":"10.1124\/jpet.110.173955_bib41","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.1210\/endo.139.9.6172","article-title":"Effect of the high-affinity estrogen receptor ligand ICI 182,780 on the rat tibia","volume":"139","author":"Sibonga","year":"1998","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/er.2003-0023","article-title":"Coregulator function: a key to understanding tissue specificity of selective receptor modulators","volume":"25","author":"Smith","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.110.173955_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0960-0760(01)00077-2","article-title":"Estrogenic influence on the regulation of hepatic estrogen receptor-\u03b1 and serum level of angiotensinogen in female rats","volume":"78","author":"Stavr\u00e9us-Evers","year":"2001","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1124\/jpet.110.173955_bib44","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1210\/en.2010-0645","article-title":"Mechanical loading-related bone gain is enhanced by tamoxifen but unaffected by fulvestrant in female mice","volume":"151","author":"Sugiyama","year":"2010","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib45","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1210\/en.2004-1064","article-title":"Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells","volume":"146","author":"Thomas","year":"2005","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib46","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1210\/endo.142.10.8528","article-title":"4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen- receptor-related (ERR) nuclear receptors \u03b2 and \u03b3","volume":"142","author":"Tremblay","year":"2001","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.110.173955_bib47","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/me.2005-0280","article-title":"The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17\u03b2-estradiol and hydroxytamoxifen in endometrial cancer cells","volume":"20","author":"Vivacqua","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.110.173955_bib48","doi-asserted-by":"crossref","first-page":"R1392","DOI":"10.1152\/ajpregu.1993.265.6.R1392","article-title":"ICI 182,780: a pure antiestrogen that affects behaviors and energy balance in rats without acting in the brain","volume":"265","author":"Wade","year":"1993","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.110.173955_bib49","doi-asserted-by":"crossref","first-page":"R1399","DOI":"10.1152\/ajpregu.1993.265.6.R1399","article-title":"ICI 182,780 antagonizes the effects of estradiol on estrous behavior and energy balance in Syrian hamsters","volume":"265","author":"Wade","year":"1993","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.110.173955_bib50","first-page":"3867","article-title":"A potent specific pure antiestrogen with clinical potential","volume":"51","author":"Wakeling","year":"1991","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.110.173955_bib51","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1093\/jn\/131.9.2351","article-title":"Sex hormones and the selective estrogen modulator tamoxifen modulate weekly body weights and food intakes in adolescent and adult rats","volume":"131","author":"Wallen","year":"2001","journal-title":"J Nutr"},{"key":"10.1124\/jpet.110.173955_bib52","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1210\/me.2007-0359","article-title":"GPR30 contributes to estrogen-induced thymic atrophy","volume":"22","author":"Wang","year":"2008","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.110.173955_bib53","doi-asserted-by":"crossref","first-page":"E490","DOI":"10.1152\/ajpendo.90691.2008","article-title":"The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice","volume":"296","author":"Windahl","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.110.173955_bib54","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1158\/0008-5472.CAN-07-1590","article-title":"Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators","volume":"67","author":"Wittmann","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.110.173955_bib55","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1159\/000059436","article-title":"Direct actions of estradiol on the anterior pituitary gland are required for hypothalamus-dependent lactotrope proliferation and secretory surges of luteinizing hormone but not of prolactin in female rats","volume":"75","author":"Yin","year":"2002","journal-title":"Neuroendocrinology"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524464458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524464458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.173955","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:32:08Z","timestamp":1740018728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524464458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022356524464458"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.173955","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tamoxifen Regulation of Bone Growth and Endocrine Function in the Ovariectomized Rat: Discrimination of Responses Involving Estrogen Receptor \u03b1\/Estrogen Receptor \u03b2, G Protein-Coupled Estrogen Receptor, or Estrogen-Related Receptor \u03b3 Using Fulvestrant (ICI 182780)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.173955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}